Updated Jul 16, 2026
Bancroft Robert E. is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.
Robert E. Bancroft is the President and CEO of AEON Biopharma, Inc., a biopharmaceutical company focused on developing innovative therapies. He has extensive experience in the biotechnology and pharmaceutical industries, contributing to the advancement of various therapeutic areas.
| Role | PRESIDENT & CEO, Director |
|---|---|
| Notability | 70/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-02-20 | AEON | AEON Biopharma, Inc. | A — Grant or award | 3.00M | $0.00 |
Robert E. Bancroft is the President and CEO of AEON Biopharma, Inc., a biopharmaceutical company focused on developing innovative therapies. He has extensive experience in the biotechnology and pharmaceutical industries, contributing to the advancement of various therapeutic areas.…
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Bancroft Robert E. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.